Compare MDXH & FRTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MDXH | FRTT |
|---|---|---|
| Founded | 2003 | 2005 |
| Country | Belgium | Canada |
| Employees | 364 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.0M | 16.1M |
| IPO Year | 2021 | 2025 |
| Metric | MDXH | FRTT |
|---|---|---|
| Price | $0.16 | $0.47 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $0.83 | N/A |
| AVG Volume (30 Days) | 1.7M | ★ 5.2M |
| Earning Date | 11-12-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.81 | N/A |
| Revenue Next Year | $13.37 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.15 | $0.43 |
| 52 Week High | $4.63 | $3.92 |
| Indicator | MDXH | FRTT |
|---|---|---|
| Relative Strength Index (RSI) | 22.87 | 28.83 |
| Support Level | N/A | N/A |
| Resistance Level | $0.64 | $1.03 |
| Average True Range (ATR) | 0.02 | 0.09 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 9.87 | 7.27 |
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
Fort Technology Inc is engaged the identification and evaluation of assets or business with a view to potentially acquire them or an interest therein by an option or any concomitant transaction.